United States Naval Medical Center, Portsmouth

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, United States Naval Medical Center, Portsmouth sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).

7 total trials 3 currently recruiting 2 completed upper quartile by trial count

United States Naval Medical Center, Portsmouth: 7 sponsored US clinical trials, 3 recruiting.

United States Naval Medical Center, Portsmouth sponsors 7 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 2 completed. 1 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Postoperative Nausea and Vomiting, with 1 trials.

Upper-quartile sponsor footprint

United States Naval Medical Center, Portsmouth sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Open and recent trials

7 total, page 1 of 1

RECRUITING Phase 4

Liposomal Bupivacaine Vs Bupivacaine with Dexmedetomidine in Erector Spinae Plane Blocks for Mastectomies

NCT06252662
RECRUITING NA

Cast Art for Kids With Extremity Fractures

NCT06990555
RECRUITING Phase 2

Preoperative Use of Pantoprazole for Prevention of Post Operative Nausea and Vomiting in Gynecologic Surgery

NCT06488001
COMPLETED NA

Using Electrical Bioimpedance Assessments to Estimate Perioperative Total Body Water and Postoperative Fluid Need

NCT02200055
TERMINATED NA

Prospective Evaluation of Symptom Resolution in Acid Versus Non-acid Reflux Disease Following Anti-reflux Surgery

NCT01241149
COMPLETED NA

Efficacy of Neonatal Release of Ankyloglossia

NCT00967915
TERMINATED

The Economic Impact of Four Varieties of Mesh Inguinal Hernia Repair- a Double-Blinded, Prospective, Randomized Trial

NCT00416364

Phase Distribution

PhaseTrial count
Phase 2 1
Phase 4 1

Therapeutic Areas

Postoperative Nausea and Vomiting 1
Fractures, Bone 1
Breast Cancer 1

What is open in the United States Naval Medical Center, Portsmouth pipeline

3 recruiting of 7 indexed (43% open); 2 completed (29%).

Phase mix: 1 late (III/IV) vs 1 early (I/II) (balanced across stages).

Top condition: Postoperative Nausea and Vomiting (1 trial), 2 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

United States Naval Medical Center, Portsmouth: open-pipeline peers nationwide

Peers matched on 7 registered trials and 43% open enrollment, not the therapeutic-area sidebar.

United States Naval Medical Center, Portsmouth sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 6.97.07.077.07.07.1 0%10%20%30%40%50% Total trials Recruiting share United States Naval Medical Center, Portsmouth3M4Life Research89bioAbbott Diagnostics DivisionAlphatec SpineClarity PharmaceuticalsColorado Center for Reproductive MedicineDavid Moss
United States Naval Medical Center, Portsmouth sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

United States Naval Medical Center, Portsmouth sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 7 trials (± recruiting share)

Sponsors near 43% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this United States Naval Medical Center, Portsmouth page

7 registered trials is a research-attention snapshot, not an endorsement of United States Naval Medical Center, Portsmouth or any single study.

  • 3 of United States Naval Medical Center, Portsmouth's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Postoperative Nausea and Vomiting is the condition United States Naval Medical Center, Portsmouth studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Postoperative Nausea and Vomiting trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

United States Naval Medical Center, Portsmouth pipeline card: 7 registered trials from official public datasets.Report a data error.